baber/WOPTO huggingface dataset:
Patent AT-E189242-T1 (AT)
Inventor: HARRIS WILLIAM J
IPC: C08G73/00
Filed: 1993-10-20
Granted: 2000-02-15
Abstract: Block copolymers may contain polybenzazole blocks and blocks of polybenzoxazinone polymer or polyoxadiazole polymer. The block copolymers may be coagulated from isotropic dopes to form shaped articles or granular compositions. The granular compositions may be compression molded to form molded articles. The block copolymers may be molded at high temperatures without substantial phase separation, and the polybenzazole polymer provides support to improve the tensile propoerties of the polymer.
Patent AT-E139641-T1 (AT)
Inventor: HORIUCHI SHIGEYUKI
IPC: A63H5/00
Filed: 1993-07-23
Granted: 1996-07-15
Abstract: A marine display is provided comprising a housing (5) and a transparent vessel (1) at least partially filled with liquid (28). A magnetic animated marine life such as a toy fish (20) is freely suspended in the liquid and at least one rotating magnet (7,8) in the housing generates magnetic fields which co-act with the magnetic toy fish (20) to cause the fish to move in all directions to simulate the swimming action of a natural fish in a liquid habitat. A background plate (6) in the housing (5) behind the liquid vessel imparts aesthetic marine-like appearance to the display. <IMAGE>
Patent AT-E226093-T1 (AT)
Inventor: FROEHLER BRIAN
IPC: A61K31/70
Filed: 1992-11-24
Granted: 2002-11-15
Abstract: An oligomer comprising at least two nucleomonomers and pharmaceutically acceptable salts thereof wherein at least one of said nucleomonomers comprises a base of formula (1) or (2): <CHEM>  wherein each X is independently O or S; R<2> is a group comprising at least one pi bond connected to the carbon atom attached to the base; Pr is (H)2 or a protecting group;  with the proviso that when at least one of said nucleomonomers of said oligomer comprises deoxyuridine 5-substituted by vinyl, 1-butenyl, 1-pentenyl, 1-hexenyl, 1-heptenyl, 1-octenyl, 1-propynyl, 1-butynyl, 1-hexynyl, 1-heptynyl, or 1-octynyl, then the remainder of the nucleomonomers comprising said oligomer are not solely comprised of phosphodiester linked 2'-deoxyadenosine, 2'deoxyguanosine, 2'-deoxycytidine, thymidine or a combination thereof; and wherein said oligomer includes at least one unit having one of thirteen specific formulas. <IMAGE> <IMAGE>
Patent AT-E150646-T1 (AT)
Inventor: GERTZ BARRY J
IPC: A61P1/02
Filed: 1992-12-08
Granted: 1997-04-15
Abstract: This invention claims a method for treating periodontal disease in mammals, including humans, by administering an effective amount of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or a pharmaceutically acceptable salt including the monosodium salt tridydrate (alendronate) of the formula:  <IMAGE>   The compounds are useful in the treatment of alveolar bone loss associated with peridontitis and periodontal disease.
Patent AT-E286137-T1 (AT)
Inventor: PAOLETTI ENZO
IPC: C12N15/09
Filed: 1993-01-07
Granted: 2005-01-15
Abstract: What is described is a recombinant poxvirus, such as fowlpox virus, containing foreign DNA from Marek's disease virus. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine.
Patent AT-E151817-T1 (AT)
Inventor: DREISTEIN WERNER FRIEDRICH
IPC: C21D9/08
Filed: 1993-02-12
Granted: 1997-05-15
Abstract: PCT No. PCT/BR93/00005 Sec. 371 Date Aug. 11, 1994 Sec. 102(e) Date Aug. 11, 1994 PCT Filed Feb. 12, 1993 PCT Pub. No. WO93/16202 PCT Pub. Date Aug. 19, 1993.A device for tempering steel tubes comprising an immersion tank (6) for cooling fluid, a chassi (2) for horizontally supporting the tube (5) to be tempered in the tank (6), means for displacing the chassi (2) from a suspended position over the tank to a second position in which the tube is inside the tank, means (3i, 4i) for maintaining the tube on the chassi so that it does not float and a cooling fluid injection nozzle (1) abuttable against an end of the tube (5) for injecting the cooling fluid into the tube. The invention provides an injection nozzle support actuable (9) for coupling the nozzle (1) to the end of the tube (5) in the suspended position and allowing it to accompany the tube to the second position.
Patent AT-E154648-T1 (AT)
Inventor: BLANCHET-FINCHER GRACIELA
IPC: B29D7/01
Filed: 1993-04-12
Granted: 1997-07-15
Abstract: A process for producing thin film of a first addition polymer on a substrate comprising bombarding a target, consisting essentially of a second addition polymer, with radiation from a pulsed laser in a vacuum or gas atmosphere to form a plume of components of said second polymer; and depositing said plume on a substrate, whereby a film of said first polymer is formed. The first and second addition polymer may be identical or different and in both cases may be fluoropolymer.
Patent AT-E143341-T1 (AT)
Inventor: SCHOENEWEISS KLAUS
IPC: B66B29/04
Filed: 1993-06-09
Granted: 1996-10-15
Abstract: PCT No. PCT/EP93/01456 Sec. 371 Date Aug. 19, 1994 Sec. 102(e) Date Aug. 19, 1994 PCT Filed Jun. 9, 1993 PCT Pub. No. WO94/05585 PCT Pub. Date Mar. 1, 1994.A safety device is disposed at a run-in region of a circulating handrail of a moving passage into a stationary wall. The safety device is made of a cover plate; an elastically deformable handrail run-in part configured as a bellows and connected to the cover plate; a rod-shaped element having a first end and a second end and being seated in a rear region of the handrail run-in part; an angled component having a first leg connected to a rear side of the handrail run-in part and a second leg adapted to receive the first end of the rod-shaped element; and a limit switch for stopping a movement of the moving passage upon being activated. The limit switch is disposed such that the rod-shaped element is effective for transmitting a deformation of the handrail run-in part onto the limit switch for activating the limit switch.
Patent AT-E147675-T1 (AT)
Inventor: BACHER WALTER
IPC: B29C33/52
Filed: 1993-06-21
Granted: 1997-02-15
Abstract: A method of making microstructure bodies of plastic material. A microstructured plate-like base body which is made by any known molding procedure and which has a first side serving as a first reference plane and a second side which has plastic microstructures projecting therefrom is covered at its second side with a material layer that engages the microstructures, whereupon the material layer is machined to provide a second reference surface parallel to the first reference surface and the base body is then machined parallel to the second reference surface to expose the microstructures projecting therefrom and the material layer is finally removed selectively with respect to the plastic material to release the microstructured bodies.
Patent AT-E184486-T1 (AT)
Inventor: PATEL SURYAKANT DAHYABHAI
IPC: C07D403/04
Filed: 1993-07-27
Granted: 1999-10-15
Abstract: PCT No. PCT/GB93/01586 Sec. 371 Date May 9, 1995 Sec. 102(e) Date May 9, 1995 PCT Filed Jul. 27, 1993 PCT Pub. No. WO94/02147 PCT Pub. Date Feb. 3, 1994A water-dispersible tablet comprising 2-amino-2-(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidine together with a swellable clay disintegrating agent and a further disintegrating agent. The tablet can be used in the treatment of neurodegenerative and other neurological disorders of the central nervous system, the etiology of which includes excessive release of neurotransmitter glutamate, including Alzheimer's disease, cerebral ischemic damage, chronic pain and epilepsy.
Patent AT-E152812-T1 (AT)
Inventor: ARNOLD NORBERT DR
IPC: C09J5/04
Filed: 1994-01-13
Granted: 1997-05-15
Abstract: Reaction-curable resin compositions based on unsaturated polyester resins, vinyl ester resins or acrylic resins are generally two-component systems, where one component contains the preaccelerated reaction-curable resin and the other component contains the curing agent. In order to ensure homogeneous curing of the components and to reduce the consumption of curing agent, based on the total amount of resin, an anchoring cartridge having two chambers is proposed, where the first chamber contains a curing agent component comprising an unaccelerated resin which cures by means of free radicals in which a certain amount of curing agent is dissolved, and the other chamber contains a resin which has been mixed with accelerator.
Patent AT-E177947-T1 (AT)
Inventor: CAVAZZA CLAUDIO DR
IPC: A61K31/20
Filed: 1994-05-25
Granted: 1999-04-15
Abstract: The use of 0-esters of L-carnitine with saturated bicarboxylic acids (e.g. azelaic, sebacic, suberic and pimelic acid) or unsaturated monocarboxylic acids (e.g. linoleic, linolenic, oleic and orachidonic acid) is disclosed for producing pharmaceutical compositions suitable to be topically applied for treating dermatoses, such as ichthyosis and psoriasis.
Patent AT-E161434-T1 (AT)
Inventor: HYPPAENEN TIMO
IPC: F23C10/18
Filed: 1994-06-07
Granted: 1998-01-15
Abstract: A method and apparatus for treating hot process gases produced in high temperature processes in a circulating fluidized bed reactor. The reactor (10) comprises a mixing chamber (12), a particle separator (16) and a return duct (18) for returning the circulating mass from the particle separator to the mixing chamber. The return opening (24) of the return duct is so arranged that the flow of solids entering the mixing chamber via the opening is directed substantially downwardly. The inlet (22) for hot process gas is so arranged as to allow the hot process gas to flow into the mixing chamber as a substantially upwardly directed solids flow so that the solids flow comes into contact with the gas flow. <IMAGE>
Patent AT-E148702-T1 (AT)
Inventor: STUCKY GERHARD DR
IPC: C07D519/00
Filed: 1994-09-15
Granted: 1997-02-15
Abstract: A novel process for the preparation of imidazopyridines of the general formula <IMAGE> wherein the radicals R1 to R4 have the meaning indicated in the description, is described. In the key step of the process an alkoxyimidate of the formula <IMAGE> is cyclised with aminoacetonitrile and with a 1,3-dicarbonyl compound of the general formula <IMAGE>   The imidazopyridines are useful intermediates for the preparation of angiotensin II antagonists.
Patent AT-E174407-T1 (AT)
Inventor: KAWAGUCHI KYOJI
IPC: F04D15/00
Filed: 1994-09-19
Granted: 1998-12-15
Abstract: A pump control system has a pump unit composed of a turbo pump, a motor for operating the turbo pump, and a frequency/voltage converter for generating a frequency and a voltage to energize the motor. The rotational speed of the turbo pump is varied in order to equalize the current of the motor to a constant current irrespective of the head of the pump. The pump can be operated to take fully advantage of the current capacity of the motor. <IMAGE>
Patent AT-E170520-T1 (AT)
Inventor: BRION JEAN-DANIEL
IPC: C07D471/06
Filed: 1994-12-13
Granted: 1998-09-15
Abstract: Compounds of general formula (I): <IMAGE>  in which A represents a divalent radical chosen from <IMAGE> and R1, R2, R3, R4, R5, R6, R7, R8, R9 and Z are as defined in the description. Medicaments.
Patent AT-E140398-T1 (AT)
Inventor: CARDUCK FRANZ-JOSEF
IPC: C11D17/06
Filed: 1993-12-13
Granted: 1996-08-15
Abstract: Granulates are particularly useful in washing and cleaning products. A homogeneous premixture is extruded at high pressures through perforated nozzles and the hank leaving the perforated nozzles is transversely severed into particules having a predetermined length by a rotary cutting knife (1), so that the particles are radially hurled away from the cutting knife (1). The particles are caught in a flexible air-permeable textile fabric (2) loosely arranged around the cutting knife (1) in the area where the particles are radially hurled. Gas, in particular air, is blown into the inner space thus formed by the textile fabric (2), and the same gas is blown onto the outer side of the textile fabric (2). The granulates are thus prevented from adhering or clinging to the inner wall of the granulating hood even at very high throughputs and whatever their recipe.
Patent AT-E142848-T1 (AT)
Inventor: CAMPBELL IAIN JAMES
IPC: A23D7/00
Filed: 1994-01-04
Granted: 1996-10-15
Abstract: PCT No. PCT/EP94/00017 Sec. 371 Date Nov. 22, 1995 Sec. 102(e) Date Nov. 22, 1995 PCT Filed Jan. 4, 1994 PCT Pub. No. WO94/15477 PCT Pub. Date Jul. 21, 1994The invention concerns coconut cream alternatives, being water continuous fat emulsions, comprising: 0.1-30wt. % vegetable fat, 0.1-5 wt. % protein compound, 0-2 wt. % emulsifier, 0-10 wt % sweetener, 0.01-5 wt. % thickener, 0.01-2 wt. % flavor, 0-1,500 ppm. multivalent cation, upon heating above 70 DEG  C. flocculation of at least the protein compound occurs.
Patent AT-E203172-T1 (AT)
Inventor: NAGANUMA MASATERU
IPC: A61M5/178
Filed: 1994-03-01
Granted: 2001-08-15
Abstract: The present invention aims at maintaining the sterilized condition of a drug-containing syringe, preventing such a syringe from being used with evil intent, simplifying the packaging of such a syringe, protecting a drug stably and making such a syringe suck an additional liquid, such as narcotic or a dissolving liquid properly and aseptically thereinto prior to injection. To achieve these objects, the present invention is constructed as follows. The portion of a syringe which extends from a cap (11) fitted around an injection needle fixing portion of an injection barrel (1) to a base end head (23) of a piston rod (22) is covered with a seal member (31) consisting of a tube (32) of a thermally shrinkable film, and the seal member (31) is closely fitted around the injection barrel by thermally shrinking the same, whereby the injection barrel (1) in which a drug (5) is sealed, a piston (21) and piston rod (22) are shut off from the outside air. The portion of the injection barrel (1) which is between the front and the rear ends of the piston (21), which has finished sealing the drug (5) therein in cooperation with the cap (11) and placed in a predetermined position in the injection barrel (1), is provided with an indication (3) of a limit of drawing the piston (21). <IMAGE>
Patent AT-E227783-T1 (AT)
Inventor: SIECK PETER A
IPC: C23C14/56
Filed: 1994-01-07
Granted: 2002-11-15
Abstract: A method of forming cylindrical end shields for use in a sputtering apparatus comprised of a rotating cylindrical magnetron within a vacuum chamber including therein at least one rotatable target structure having an outer cylindrically-shaped surface of sputtering material and held at opposite ends thereof by first and second support structures, a magnet assembly within said target structure that provides a magnetic field zone, and first and second cylindrical end shields carried at opposite ends of said target structure by said support structures, said first shield having an inner edge closest to said second shield and said second shield having an inner edge closest to said first shield, said inner edges positioned adjacent to said magnetic field zone, comprising the steps of:   (a) operating said rotating cylindrical magnetron such that said magnetic field zone is provided; (b) measuring said magnetifc field zone such that a magnetic field pattern is obtained; and (c) shaping said shields at said inner edges to conform substantially to the isomagnetic lines of said magnetic field pattern.   <IMAGE>
Patent AT-E198621-T1 (AT)
Inventor: THOMPSON CRAIG BERNIE
IPC: A01K67/027
Filed: 1994-05-25
Granted: 2001-01-15
Abstract: A mammal lacking expression of particular CD45 isoform in certain cells of the immune system is provided. The mammal may optionally contain a transgene encoding the CD45RO isoform. Also provided are methods of using these mammals.
Patent AT-E237989-T1 (AT)
Inventor: HYNSON JAMES M
IPC: A61B5/022
Filed: 1995-08-29
Granted: 2003-05-15
Abstract: The vascular resistance to blood flow through the hand is increased in an essentially uniform manner by the application of pressure to the hand. The pressure is applied by means of an inflatable bladder mounted on an arm board or within a non-expandable sleeve, mitten or glove, which bladder covers at least the palm of the hand. Controlled inflation of the bladder conveys pressure to the hand tissue to a degree necessary to compress vascular structures and obstruct or restrict blood flow. By occluding blood flow through the hand, more accurate invasive blood pressure readings can be taken in clinical situations where decreased hand vascular resistance occurs. <MATH>
Patent AT-E160593-T1 (AT)
Inventor: TERRAT JEAN-PAUL
IPC: C23C22/50
Filed: 1995-02-01
Granted: 1997-12-15
Abstract: A salt bath compsn., contg. nitrate anions and sodium and opt. potassium cations, used at 320-550 degrees C for surface oxidn. of esp. nitrided ferrous metal parts to increase their corrosion resistance, includes 0.1-5 (pref. 0.5-1.75) wt.% lithium cations substituting sodium or potassium cations.
Patent AT-E217027-T1 (AT)
Inventor: FACH PATRICK
IPC: C07K14/33
Filed: 1994-12-22
Granted: 2002-05-15
Abstract: Specific primers useful for the detection of the presence of lecithinase or enterotoxin genes or the presence of Clostridium perfringens bacteria in a sample by a polymerase chain reaction, particularly, in food sample or fecal samples.
Patent AT-E344038-T1 (AT)
Inventor: SPONA JUERGEN VITALOGIC
IPC: A61P15/18
Filed: 1994-12-22
Granted: 2006-11-15
Abstract: Conception is prevented in a fertile female who has not reached the pre-menopause by the admin. over a 28 day cycle of a combination of: (a) an estrogen content comprising: 2-6 mg 17beta -oestradiol or 0.015-ethynyloestradiol; and (b) a gestagen content comprising: 0.05-0.075 mg gestodene; 0.075-0.125 mg levonorgestrel; 0.06-0.15 mg desogestrel or 3-ketodesogestrel; 0.1-0.3 mg drospirenone; 0.1-0.2 mg cyproterone acetate; 0.2-0.3 mg norgestimate or > 0.35 mg to 0.75 mg norethisterone; for 23 or 24 days commencing on day 1 of the menstruation cycle followed by 5 or 4 days without this medication or with a placebo. Also claimed is a contraceptive pack contg. 23 or 24 dosage units contg. the oestrogen and gestagen components and 5 or 4 placebos or other instructions to the effect that 5 or 4 days without medicament or with placebo should follow the admin. of a dosage unit for 23 or 24 consecutive days; with the estrogen content being: > 2 mg to 6 mg oestradiol or 0.02 mg ethynyloestradiol; and the gestagen content being: above 0.06-0.075 mg gestodene, > 0.1-0.125 mg levonorgestrel, > 0.1-0.15 mg desogestrel or 3-ketodesogestrel, 0.25-0.3 mg drospirenone, 0.1-0.2 mg cyproterone acetate, 0.2-0.3 mg norgestimate or 0.5-0.75 mg norethisterone.
Patent AT-E167644-T1 (AT)
Inventor: KISS GUENTER H
IPC: G09F13/16
Filed: 1995-02-15
Granted: 1998-07-15
Abstract: The invention concerns a process for the storage of heterogeneous wastes in holding or supply dumps, such as rubbish bunkers or suitable rubbish containers, prior to its removal and subsequent thermal utilization or some other processing technique. By introducing a variable flow of inert gas consisting essentially of nitrogen and carbon dioxide into the rubbish bunker, fires and gas explosions are practically excluded, aerobic decomposition processes are suppressed, and anaerobic decomposition is retarded. Using a variable flow of inert gas also prevents the further formation of dioxins and furans in a subsequent thermal utilization, as well as reliably preventing vermin from attacking the rubbish. By avoiding or at least significantly reducing these disturbances in the bunker zone, disposal safety is significantly increased. Storage of the wastes preferably takes place in an essentially inert atmosphere which is introduced into the rubbish bunker adjacent the bottom so that the inert gas flows upwardly through the rubbish. Storage of the wastes in an inert atmosphere essentially prevents the occurrence of a fire.
Patent AT-E222494-T1 (AT)
Inventor: LACHNIT URSULA
IPC: A61P15/18
Filed: 1995-03-30
Granted: 2002-09-15
Abstract: PCT No. PCT/EP95/01190 Sec. 371 Date Dec. 16, 1996 Sec. 102(e) Date Dec. 16, 1996 PCT Filed Mar. 30, 1995 PCT Pub. No. WO95/26730 PCT Pub. Date Oct. 12, 1995A pharmaceutical combination preparation with two hormone components that are manufactured physically separately in a packaging unit and that are intended for time-sequential oral administration, which in each case consist of a number of daily dosage units that are placed physically separately and are individually removable in the packaging unit. As a hormonal active ingredient, a first hormone component contains in combination an estrogen preparation and, in at least a dosage that is sufficient to inhibit ovulation, a gestagen preparation, and as a hormonal active ingredient the second hormone component contains only an estrogen preparation. The first hormone component comprises 23 or 24 daily units and the second hormone component comprises 4 to 10 daily units. The total number of hormone daily units is equal to the total number of days of the desired cycle, but at least 28 days in length. This combination preparation is used for female birth control, and allows for an estrogen content that is as low as possible in each individual dosage unit and also has a low total hormone content per administration cycle, with high contraceptive reliability, low incidence of follicular development, and satisfactory cycle control, with reliable avoidance of intracyclic menstrual bleeding as well as of undesirable side-effects.\!
Patent AT-E197971-T1 (AT)
Inventor: ALKIRE ROBERTA LEE
IPC: B29C63/04
Filed: 1995-09-20
Granted: 2000-12-15
Abstract: An irregularly shaped glass fiber is provided which enjoys improved resiliency, and openness in pack structures. Wool packs and other wool portions having such irregularly shaped fibers may be processed directly through needling to form a non-woven material without intervening steps such as carding or blending of fibers which accompany conventional glass fiber processing operations. In a further aspect of the invention, a non-woven material including irregularly shaped fibers in a generally continuous wool tow is produced by "unwinding" a fiberglass wool pack collected by a direct forming method. Product applications include simplified, lower cost processing, and new uses of the irregularly shaped fibers produced by rotary fiberization in filtration elements, sorbants, gaskets, packings, shingles, composite structural elements, furnishings, textiles, yarns, and blown-in insulation systems.
Patent AT-E182687-T1 (AT)
Inventor: HAWORTH DAVID PATRICK
IPC: G01S1/02
Filed: 1995-09-20
Granted: 1999-08-15
Abstract: PCT No. PCT/GB95/02211 Sec. 371 Date Mar. 20, 1998 Sec. 102(e) Date Mar. 20, 1998 PCT Filed Sep. 20, 1995 PCT Pub. No. WO97/11383 PCT Pub. Date Mar. 27, 1997A method of determining the location of an unknown source (10) transmitting an unknown signal to satellite relays (14 and 16) comprises receiving the signal from the relays at respective receivers (18). The receivers (18) receive reference signals via respective relays from a common source (22). The unknown signal and reference signal received by each receiver (18) are processed coherently to preserve their timing and phase information relative to one another independently of signals received elsewhere. The signals are frequency downconverted and digitised, and transferred to a common processing computer (150). The computer (150) performs cross ambiguity function processing of the reference signals to determine their relative Differential Time Offset (DTO) and Differential Frequency Offset (DFO). It performs the like for the received unknown signals to determine relative DTO and DFO, relative time and frequency shifts being introduced between the unknown signals by incorporation of the reference signal DTO and DFO in order to enable the unknown signal DFO to be determined relative to the reference signal DFO. The reference signals are also employed to counteract phase noise and frequency drift effects in the unknown signals. From the unknown signal DTO and DFO the position of the unknown source (10) is calculated.